FY2026 EPS Estimates for MannKind Cut by Leerink Partnrs

MannKind Corporation (NASDAQ:MNKD – Free Report) – Investment analysts at Leerink Partnrs decreased their FY2026 earnings per share estimates for shares of MannKind in a report released on Wednesday, June 18th. Leerink Partnrs analyst F. Khurshid now forecasts that the biopharmaceutical company will post earnings of $0.14 per share for the year, down from their […]

Leave a Reply

Your email address will not be published.

Previous post Equities Analysts Offer Predictions for CGBD Q1 Earnings
Next post Roth Capital Cuts Earnings Estimates for ReNew Energy Global